“…As clinicians shaping structural heart clinical pathways, we anticipated a similar trajectory for structural heart therapy, launched SDD, 8 and crafted frameworks for program optimization and systems of care. 13 We envisioned a not-too-distant future of ambulatory surgical centers for transcatheter structural heart intervention, provided that emergency care protocols and U.S. reimbursement concerns could be thoughtfully mitigated. These strategies may be more favorable for transcatheter mitral edge to edge repair, 18 , 19 left atrial appendage occlusion, and transcatheter closure of patent foramen ovale or interatrial septal defects, which have decreased risk of conduction disorder/permanent pacemaker or vascular complications as compared to TAVR.…”